Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers

Completed · Phase 1

Conditions studied: Parkinson Disease

In brief

This study investigates the initial safety profile of \[18F\]P17-059 in healthy volunteers including dosimetry determination, and compares regional brain uptake and kinetics of \[18F\]P17-059 in Parkinson's disease patients with regional brain uptake and kinetics of \[18F\]P17-059 in healthy volunteers.

Key facts

Study ID

NCT03903549

Run by

Five Eleven Pharma, Inc.

People needed

4

Starts

2022-07-15

Expected to finish

2022-12-19

Last updated by the study team

2023-01-11

Who can join

Age: 45 and older, up to 90. Sex: any. Healthy volunteers: accepted.

Where it is running

• Johns Hopkins Medical Institutions — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.